Sector: Pharmaceuticals & Biotechnology

Mid Cap

Concord Biotech Share Price

Concord Biotech Ltd.

₹1,103

5.10(0.46%)

Invest in CONCORDBIO with up to 2.50x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : CONCORDBIO

Open Free Demat Account

Concord Biotech Performance

Price Movement

₹1103.00

₹1079.90

₹1126.90

↘ Today's Low↗ Today's High

1 Year Performance

₹1103.00

₹1090.30

₹2150.40

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,126.90

Low₹1,079.90

Open at₹1,119.60

Prev Close₹1,097.90

Volumes91.86 K

Avg Price₹1,098.50

Lower Circuit₹878.40

Upper Circuit₹1,317.40

Historical Performance

3M High₹1,455.00

3M Low₹1,079.90

1 Yr High₹2,150.40

1 Yr Low₹1,079.90

3 Yr High₹2,664.00

3 Yr Low₹900.05

5 Yr High₹2,664.00

5 Yr Low₹900.05

Concord Biotech Fundamentals

Market Cap

Market Runner Up

11,500.50 Cr.

PE Ratio (TTM)

Below industry Median

36.80

Dividend Yield

Market Runner Up

Net Profit TTM

4% decr over last year

312.50

Net Profit Growth

4% decr over last year

312.50

PEG Ratio

Negative PEG TTM

-8.70

ROE

1.6% incr over last year

20.50

Operating Revenue TTM

1,158.69

Operating Revenue Growth

6.4% incr over last year

Book Value

Below industry Median

6.30

MFI

MFI strongly Overbought

83.59

RSI

RSI is mid-range

34.12

EPS (TTM)

35.52

Debt to Equity

Face Value

Operating Profit Margin Qtr.

40.68

Operating Profit Qtr.

98.98

Net Profit Qtr.

64.48

Operating Revenue Qtr.

277.77

PB Ratio

6.30

Concord Biotech Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	278.13	247.06	203.99	429.88	244.22
Operating Expense	175.91	156.52	142.59	239.46	146.27
Operating Profit	102.22	90.54	61.40	190.42	97.95
Depreciation	18.67	18.39	17.78	14.62	13.26
Interest	0.06	0.06	0.06	0.10	0.10
Tax	22.51	22.62	14.67	43.16	25.23
Net Profit	67.78	62.90	42.57	141.94	74.09

Concord Biotech Technicals

Concord Biotech Ltd. EMA & SMA

₹1103.00

5.10 (0.46%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1135.4

Day EMA10 ₹1163.9

Day EMA12 ₹1171.4

Day EMA20 ₹1195.6

Day EMA26 ₹1211.5

Day EMA50 ₹1268

Day EMA100 ₹1366.3

Day EMA200 ₹1492.4

Concord Biotech Support and Resistance

Resistance

First Resistance₹1118.50

Second Resistance₹1139.10

Third Resistance₹1153.20

Support

First Support₹1083.80

Second Support₹1069.70

Third Support₹1049.10

Technical Indicators

Day RSI34.12

Day MFI83.59

Day ADX22.72

Day Commodity Channel Index-131.40

William-97.42

Day MACD-40.04

Day MACD Signal Line-32.77

Day ATR53.17

Day ROC125-37.27

Day ROC21-13.08

Concord Biotech Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	44.1	44.1	44.1	44.1	44.1	44.1
FII	8.1	8.3	9.4	9.1	8	7.6
DII	9.9	9.7	9.1	8.9	9.6	9.6
Public	38	37.9	37.4	37.9	38.3	38.8

Concord Biotech Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	38.06 K	85.37 K	44.58%
Week	39.55 K	88.13 K	44.88%
1 Month	60.45 K	3.17 L	19.06%
6 Month	60.72 K	1.4 L	43.42%

Concord Biotech SWOT Analysis

Strengths15

Weakness10

Opportunity1

Threats1

Benjamin Graham Value Screen

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Volume Shockers

Concord Biotech Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
03 Sep, 2025	10.7	FINAL	03 Sep, 2025	Equity Share
21 Jun, 2024	8.75	FINAL	22 Jun, 2024	Equity Share

Concord Biotech Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.
Price (₹)	₹1,577	₹628.95	₹780	₹968	₹1,320	₹4,075
% Change	3.47%	-5.40%	-0.01%	2.83%	3.96%	0.75%
Revenue TTM (₹ Cr)	-	-	₹1,598.19	₹2,169.86	₹1,419.33	₹798.10
Net Profit TTM (₹ Cr)	-	-	₹206.20	₹332.94	₹20.10	₹217.90
PE TTM	-	-	62.20	61.50	754.90	43.10
1 Year Return	48.29	6.51	60.63	37.17	3.9	-12.48
ROCE	30.24	34.78	34.76	12.51	3.26	-

Similar Stocks

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 474.00

-0.91%

BLUEJET

Blue Jet Healthcare Ltd

₹ 391.40

+9.99%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 687.60

-1.60%

SUPRIYA

Supriya Lifescience Ltd.

₹ 670.00

-1.17%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2138.50

+1.52%

ALIVUS

Alivus Life Sciences Ltd.

₹ 901.15

-1.08%

COHANCE

Cohance Lifesciences Ltd.

₹ 315.10

+3.18%

ERIS

Eris Lifesciences Ltd.

₹ 1358.00

+1.16%

SYNGENE

Syngene International Ltd.

₹ 448.60

+1.33%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 774.90

+1.55%

STAR

Strides Pharma Science Ltd.

₹ 872.90

+0.37%

GRANULES

Granules India Ltd.

₹ 598.00

-0.18%

FDC

FDC Ltd.

₹ 383.00

+3.82%

SHILPAMED

Shilpa Medicare Ltd.

₹ 329.00

+1.29%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 900.00

+3.15%

NATCOPHARM

Natco Pharma Ltd.

₹ 886.00

-0.64%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1739.00

+2.77%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 13507.00

+6.88%

MARKSANS

Marksans Pharma Ltd.

₹ 179.32

+0.53%

SANOFI

Sanofi India Ltd.

₹ 4080.00

+1.34%

PGHL

Procter & Gamble Health Ltd.

₹ 5080.00

+1.21%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 674.90

-2.16%

FAQ's on CONCORDBIO

What is the current share price of Concord Biotech Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Concord Biotech Ltd. is ₹ 1103 on the NSE and ₹ 1103.75 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Concord Biotech Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Concord Biotech Ltd. is approximately ₹ 11500.5 Cr.

What are the PE and PB ratios for Concord Biotech Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Concord Biotech Ltd. is 36.8, and the Price-to-Book (PB) ratio is 6.3.

What is the 52-Week High and Low for Concord Biotech Ltd.?

Over the past 52 weeks, the highest price reached by Concord Biotech Ltd. shares was ₹ 2150.4, and the lowest price was ₹ 1079.9.

What is the current dividend yield for Concord Biotech Ltd.?

As of 6 June 2025, the dividend yield for Concord Biotech Ltd. is 1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Concord Biotech Ltd.?

Significant shareholdings in Concord Biotech Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions
Mutual Funds

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Concord Biotech Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Concord Biotech Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Concord Biotech Ltd.?

Concord Biotech Ltd. last declared a FINAL dividend of ₹ 10.7 per share for the financial period ending 2025. The record date was set as 2025-09-03, and the payment was/is scheduled around 2025-09-03. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy